<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04723485</url>
  </required_header>
  <id_info>
    <org_study_id>KJPP 2019-00230</org_study_id>
    <nct_id>NCT04723485</nct_id>
  </id_info>
  <brief_title>Evaluation Study: Obsessive-compulsive Disorders in Childhood and Young Adulthood</brief_title>
  <official_title>Evaluation Study: Obsessive-compulsive Disorders in Childhood and Young Adulthood</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Susanne Walitza</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Psychiatric University Hospital, Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Obsessive-compulsive disorders are very damaging illnesses that can already manifest in&#xD;
      childhood and adolescence. With an average prevalence from 1 - 3%, they are one of the most&#xD;
      frequently diagnosed psychiatric illness in these age groups. With the further use of data,&#xD;
      the treatment success can be significantly improved; causal variables/predictors can be&#xD;
      recognized, understood and taken carefully into account. The anticipated incremental&#xD;
      knowledge will ultimately help children and young people with obsessive-compulsive disorders&#xD;
      to receive faster and more effective treatment.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2020</start_date>
  <completion_date type="Anticipated">March 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Symptoms severity of obsessive and compulsive symptoms in children and adolescents</measure>
    <time_frame>24 months</time_frame>
    <description>The clinician report questionnaire (BY-BOCS) contains 19 items designed to assess severity of obsessive and compulsive symptoms in children and adolescents.The test uses a four point scale to rate the severity of their obsessive compulsive behaviors. Higher score means a worse outcome.</description>
  </primary_outcome>
  <enrollment type="Anticipated">625</enrollment>
  <condition>Obsessive-compulsive Disorder</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The sample consist of pupils with obsessive-compulsive disorder 4 to 18 years&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Children and young people from 8-18 years of age who fulfill the international&#xD;
             classification of diseases tenth edition (ICD-10) , obsessive-compulsive disorder&#xD;
             handled in our clinic.&#xD;
&#xD;
          -  Good German language speaking skills&#xD;
&#xD;
          -  IQ &gt; 75&#xD;
&#xD;
          -  All study participants or their legal representative have given written permission for&#xD;
             their experiences to be documented in the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Schizophrenia-related disorders (psychoses)&#xD;
&#xD;
          -  Missing data&#xD;
&#xD;
          -  Data sets without confirmed diagnosis&#xD;
&#xD;
          -  Purely consultaive patient interview (no therapy intervention prescribed)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susanne Walitza, Prof. Dr. med. Dipl.-Psych.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sponsor-Investigator</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Susanne Walitza, Prof. Dr. med. Dipl.-Psych.</last_name>
    <phone>+41 (0)43 499 26 26</phone>
    <email>susanne.walitza@puk.zh.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Juliane Ball, Dr. rer. Nat. Dipl. Psych</last_name>
    <phone>+41 43 499 26 26</phone>
    <email>juliane.ball@puk.zh.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Psychiatric University Clinics, Department of Child and Adolescent Psychiatry</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susanne Walitza, Prof. Dr. med. Dipl.-Psych.</last_name>
      <phone>+41 43 499 26 26</phone>
      <email>susanne.walitza@puk.zh.ch</email>
    </contact>
    <contact_backup>
      <last_name>Siebke Melfsen, Dr.</last_name>
      <phone>+49 45 42 98 69 77 4</phone>
      <email>siebke.melfsen@online.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 21, 2021</study_first_submitted>
  <study_first_submitted_qc>January 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 25, 2021</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Psychiatric University Hospital, Zurich</investigator_affiliation>
    <investigator_full_name>Susanne Walitza</investigator_full_name>
    <investigator_title>Head of the Department of Child and Adolescent Psychiatry</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Compulsive Personality Disorder</mesh_term>
    <mesh_term>Obsessive-Compulsive Disorder</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

